Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer
Dr. Linh Alejandro, a clinical oncology pharmacist at the University of California, San Diego Health Systems discusses the approval of olaparib for germline BRCA-mutated metastatic breast cancer.
